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Summary 
Rejection of H-Y-bearing primary skin grafts and generation of H-Y-specific cytolytic T  cells 
by female mice requires the participation of both CD4 + and CD8 + T lymphocytes. Studies were 
conducted to investigate long-term tolerance of H-Y antigen induced in female mice by transiently 
depleting them of CD4 § and/or CD8 + T cells and, at the same time, giving them an injection 
of male lymphoid cells. We confirmed that after recovery of CD4 + to normal levels, female mice 
that had been transiently depleted of CD4 + cells and concurrently given an injection of male 
spleen cells were unable to generate H-Y-specific cytolytic T  cells. Tolerance was also manifest 
by greatly extended survival (probably permanent in most cases)  of male skin grafts.  Further 
investigations revealed that female mice transiently depleted of CD8 + cells,  and concurrently 
given an injection of male spleen cells, were similarly tolerant of H-Y antigen later when numbers 
of CD8 + T  cells returned to normal.  Moreover,  small numbers of male cells were detectable 
in spleen and lymph nodes of tolerant females long after they had been given an injection of 
male cells and depleted of either CD4 + or CD8 + T  cells, whereas no male cells were detected 
in (nontolerant) females given male cells and control antibodies. These findings show that tolerance 
of the relatively weak transplantation antigen, H-Y, can be achieved simply by giving male antigen- 
bearing spleen cells to the host while it is transiently depleted of a type of cell it needs in order 
to reject those cells, thus allowing the male cells to persist in the host. Furthermore, depletion 
of helper cells is not obligatory to achieve tolerance.  It has been hypothesized that tolerance 
of H-Y  antigen in females given male lymphoid cells while temporarily depleted of CD4 + 
lymphocytes results from unresponsiveness (anergy) induced in H-Y-specific CD8 + cells that 
are exposed to H-Y  antigen in the absence of help from CD4 § cells.  Interpretations of our 
findings are discussed in relation to this hypothesis. 
IA :hough it has been well established that  tolerance of 
some self-antigens is due mainly to clonal deletion of 
self-reactive T cells in the thymus, it is unclear how tolerance 
is induced to cell-associated antigens not expressed in the 
thymus. Understanding how tolerance can be induced ex- 
trathymically has important implications for attempts to es- 
tablish a nonresponsive state to allogeneic antigens borne on 
tissue grafts and for reestablishing self-tolerance in patients 
suffering from autoimmune diseases. 
Bretscher and Cohn (1) have proposed a theory that can 
account for extrathymic tolerance induction. Although ini- 
tially proposed as a model for cooperation between T  and 
B cells in an immune response, the theory can be applied 
to systems involving only T  cell responses (2).  In essence, 
the theory says that in order for an antigen to be immuno- 
genic when encountered by a potentially reactive T cell, an- 
tigen recognition must be accompanied by a costimulatory 
second signal, provided to potentially reactive CD4 + T cells 
by APCs, or to potentially reactive CD8 + T cells by CD4 + 
T helper cells. However, if antigen is encountered in the ab- 
sence  of a  costimulus,  the  potentially  reactive  CD4 +  or 
CD8 + T  cell is rendered tolerant of the antigen, and fails 
to respond on subsequent encounters with it, even if accom- 
panied by an appropriate costimulus. 
In vitro studies lend credibility to this hypothesis (for a 
review see reference 3). It is also supported by results of ex- 
periments performed in mice involving the Qa-1 antigen (2, 
4).  Primary Qa-l-disparate  skin grafts are not rejected by 
host mice unless the graft bears additional antigenic deter- 
minants, such as H-Y antigen, which are rejectable on their 
own. In such cases,  the host can reject grafts later on that 
bear the Qa-1 disparity alone. In contrast, if the initial graft 
bears only the Q-1 disparity, then the host is unable to reject 
another graft of this type later on, even if it is accompanied 
by H-Y antigen. These results have been interpreted to mean 
that H-Y antigen stimulates helper cells, whereas the Qa-1 
antigen by itself does not. The help provided by H-Y-stimu- 
lated cells provides a costimulus to potential anti-Qa-1 effectors. 
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Qa-1  effector cells become tolerized upon encounter with 
the Qa-1 antigen, and are unable to respond later on, even 
if help is provided. 
Others have performed experiments in which the H-Y an- 
tigen itself was the target for tolerance induction (2, 5). Fe- 
male mice were  temporarily depleted of CD4 +  cells  and 
concurrently given an injection of male lymphoid cells. Weeks 
later,  when  the  number  of CD4 +  cells  had  returned  to 
normal, the females were challenged with male cells to de- 
termine whether they could be primed to generate H-Y-specific 
CTL. They were unable to, however, unlike control mice that 
had not received male cells. The authors concluded that ex- 
posure of potentially H-Y-reactive female CD8 + T cells to 
male antigen-bearing cells at a time when CD4 + cells were 
not  available  to  provide  help  rendered  the  CD8 +  cells 
tolerant and unable to respond later on after repopulation 
of CD4 + cells. It should be noted that generation of H-Y- 
specific cytolytic T cells by female mice requires  the partici- 
pation of both CD4 + and CD8 + T  cells, as does rejection 
of primary male skin grafts (6). 
Two points about this experiment require comment. Toler- 
ance was not assessed using skin grafts. This is relevant be- 
cause in some circumstances female mice can reject H-Y-in- 
compatible skin grafts even though they cannot be primed 
to generate H-Y-specific CTL (7-9). Also, it was not deter- 
mined whether it was the CD8 + T  cells, rather than the 
CD4 + cells which repopulated the hosts, that were actually 
tolerized. The Bretscher and Cohn hypothesis predicts toleri- 
zation of the CD8 § population in this experiment. 
The following experiments were undertaken to investigate 
in more detail the process of tolerance induction by the method 
just outlined. First, we wanted to determine whether the mice 
were tolerant of H-Y by the criterion of acceptance of male 
skin grafts. Furthermore, we wished to determine whether 
it is obligatory to deplete helper cells in order to establish 
tolerance, and whether we could detect persistent male cells 
in tolerant female hosts. 
Materials and Methods 
Mice.  C57BL/6J  (abbreviated B6), B6.C-H-2a/aBy (Hw19), 
B6.PL-T~-I~  (B6-Thy-l.1), and BALB/cBy x  B6)F1 (CB6F1) 
mice were bred in a barrier-sustained facility at the Trudeau Insti- 
tute from founder stocks obtained from the Jackson Laboratory 
(Bar Harbor, ME). Animals were age matched in each experiment 
and maintained under controlled temperature and light/dark con- 
ditions. They received commercial laboratory chow and acidified 
water ad libitum. Serum samples were taken regularly from sen- 
tinel mice and analyzed (Research Animal Diagnostic and Inves- 
tigative Laboratory, University of Missouri, Columbia, MO) to 
verify  the absence of  microbial  pathogens that might adversely  affect 
immunological functions. 
mAbs.  mAbs  GK1.5 (ratlgG2b, American Type Culture Col- 
lection [ATCC, R.ockville, MD] TIB 207) and 2.43 (rat IgG2b 
ATCC TIB 210) were used to deplete CD4 + and CD8 + ceils, 
respectively, mAb-containing ascites grown in CB6F~ mice were 
purified by 45% ammonium sulfate precipitation and DEAE ion- 
exchange  chromatography.  Eluted mAbs were dialyzed  against PBS, 
sterile filtered, and frozen at -70~  until used. FITC-conjugated 
F(ab')2 fragments of GK1.5, 2.43, or the anti-Thy-l.2 mAb 30H12 
(ATCC TIB 107) were also used for flow cytometric analyses. In 
some experiments, culture supernatant of the anti-Ia  b/d hybridoma 
28-16-8S (ATCC HB35) was used, with rabbit complement, to en- 
rich numbers of Thy-1  + cells in spleen and lymph node cell prepa- 
rations by eliminating MHC class II + cells. 
Depletion of T  Cell Subsets In  Vivo.  Mice were depleted of 
CD4 § or CD8 + cells essentially  as described by Guerder and Mat- 
zinger (2). Briefly, 5-7-wk-old females were given two intraperi- 
toneal injections containing I mg each of the appropriate antibody 
24 h apart. Control mice received equal amounts of normal rat 
IgG (ICN Biomedicals, Inc., Costa Mesa, CA). Flow cytometric 
analysis (FACScan  |  Becton Dickinson & Co., Mountain View, 
CA) confirmed that depletion of CD4 + or CD8 § spleen cells was 
~99% 3 d after the last injection. Weekly flow cytometric analysis 
of spleen cells from antibody-treated  mice also showed that repopu- 
lation of depleted cells began about 2 wk after the last antibody 
injection and stabilized at near normal levels by 9 wk. 
Spleen Cell Preparation.  Cell suspensions were made by gentle 
mechanical  disruption of  B6 male  or female  spleens  in ice-cold  Hepes- 
buffered HBSS. After washing in HBSS, cells were suspended at 
10S/ml for primary injections, or at 2  x  107/ml for CTL priming. 
Primary injections of 5  x  107 cells were given intraperitoneally 
6 h after the last mAb injection. Cells for CTL priming (107 per 
host) were injected 9 wk after the primary cell injections. 
CTL Assays.  Between 2 and 4 wk after mice were given cells 
for CTL priming, cultures of spleen cells from treated B6 females 
were initiated to generate H-Y-specific  CTL by a slight modification 
of previously  described methods (9). Briefly,  ,,o5 x  107 B6 female 
spleen cells  were incubated  with a similar  number of  irradiated  (2,000 
rad) B6 male stimulator cells or control Hw19 female stimulator 
cells for 5 d. Approximately 107 B6 male (H-Y antigen), B6 fe- 
male (negative control), or Hw19 female (MHC alloantigen posi- 
tive control) spleen cells depleted of RBC by hypoosmotic shock 
were cultured in medium containing 2.5 #g/ml Con A (Sigma 
Chemical Co., St. Louis, MO) or 10 #g/ml Salmonella enteriditis 
LPS (Difco Laboratories,  Inc., Detroit, MI) for 48 h to obtain lym- 
phoblasts for use as targets. Labelling of target blasts and assay  of 
cytolytic activity were carried out as described (9). 
Skin Grafting.  Tolerance  of  H-Y antigen by treated females  was 
assessed in vivo by survival of orthotopic male tailskin grafts (10, 
11). Skin graft survival times in different groups were compared 
using the one-tailed Wilcoxon two sample rank-sum test (12). 
Persistence of Injected Male Lymphocytes.  Cells  (2  x  107/ml) ob- 
tained from B6 (Thy-l.2) male  donor spleens and lymph nodes (axial, 
brachial, and inguinal) were incubated for 45 min on ice with cul- 
ture supernatant from an anti-Ia  TM hybridoma, washed, and in- 
cubated with rabbit complement for 60 min at 37~  to reduce 
numbers  of macrophages and  Ia + B  lymphocytes. Cells were 
washed, counted, and injected intraperitoneally at 5  x  107 per 
host into female B6-Thy-l.1 mice that were treated with mAbs, 
to deplete CD4 + or CD8 + cells, or with control rat IgG. FACS  | 
analysis (Becton Dickinson & Co.) revealed that about 80% of the 
injected cells were positive for the Thy-l.2 marker. 
At 1, 5, and 9 wk after injection of Thy-l.2 + male lymphoid 
cells into B6-Thy-l.1 females, their spleens and lymph nodes were 
removed, depleted of Ia* cells as previously described, and ana- 
lyzed by flow  cytometry for Thy-l.2 + male  donor cells. There was 
no detectable staining of control Thy-l.1 + cells by the anti-Thy- 
1.2-specific antibody. 
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ments were performed to confirm the findings of others (2) 
regarding tolerance induction detectable by CTL assays. Fe- 
male B6 mice depleted of CD4 + cells,  or given control rat 
IgG, were given an injection of male spleen cells as described 
and allowed to recover for 9 wk. At that time, CD4 * spleen 
cells had returned to about 90% of the number found in non- 
depleted age-matched controls. Mice in various groups were 
challenged with an intraperitoneal  injection of male spleen 
uJ 
m  60-  < 
uJ 
--~  50.  ,,I 
re 
40' 
O 
g  30. 
=E 
￿9  ",  20" 
x  10.  < 
~  O' 
a 
A---.--~_.A  A 
2:5  6  10 
b 
2.5  10  40 
RESPONDER  CELLS  /  TARGET 
Figure  1.  Percent slCr-rehase from labded B6 male LPS (a) or Con 
A (b) target blasts in CTL assays. Effector  cells generated in vitro from 
spleen cells  from females treated initially with depleting mAb and B6 male 
spleen cells (A), depleting mAb and B6 female spleen cells (V), control 
rat IgG, and male spleen cells (O), or control rat IgG and female spleen 
cells (e). mAbs used for depletion were anti-CD4 (a) or anti-CD8 (b). 
(I) Labd release from Hw19 targets by effeetors from females treated 
initially with depleting mAb and male spleen cells. Label  release from fe- 
male targets was negative. 
cells to see whether they could be primed for generation of 
H-Y-specific CTL in vitro (Fig. 1 a). H-Y-specific CTL ac- 
tivity was generated in cultures  of spleen cells  taken from 
females treated at the outset with control rat IgG and either 
male or female spleen cells, or from females treated with an- 
tibodies that depleted CD4 + cells and given female cells. In 
contrast,  no H-Y-specific CTL activity was obtained from 
females treated initially with anti-CD4 antibodies and given 
male  spleen cells,  although  activity was generated  against 
MHC-disparate Hwl9 targets (control), indicating that the 
tolerance was H-Y specific. 
To evaluate tolerance wholly in vivo, female mice receiving 
the same initial treatments with antibodies and male or fe- 
male spleen cell injections were given grafts of B6 male skin 
9 wk later, rather than being challenged for CTL priming. 
The results (Table 1) dosely paralleled those of the CTL studies. 
Almost all of the mice depleted of CD4 + and given an in- 
jection of male spleen cells at the outset were unable to reject 
male skin grafts, whereas male skin grafts were rejected by 
females in the other groups. Survival of male skin grafts on 
rat IgG-treated females given male spleen cells was somewhat 
extended,  a finding consistent with a previously published 
report  (13). 
Tolerance in Females Depleted of CD8 + Cells.  In experi- 
ments similar to those involving females depleted of CD4 + 
cells,  female B6 mice were treated with anti-CD8  mAb or 
control rat IgG and given injections of either male or female 
spleen cells. Treated mice were challenged with male spleen 
cells at 9 wk for CTL priming or were given grafts of male 
skin. Similar to findings in mice depleted of CD4 + cells, fe- 
males depleted of CD8 + cells  and given male spleen cells 
Table  1.  Survival of Male Tail Skin Grafts on B6 Females Temporarily Depleted of CD4 + T  Cells 
Group  mAb treatment  Injected cells  Skin graft  survival 
Experiment  1  d 
A  Control rat  IgG  B6 female"  15, 24,  24,  24,  28* 
B  Control rat  IgG  B6 male  28,  35,  52,  70,  109s 
C  anti-CD4  B6 female  21,  24,  28,  28,  28 
D  anti-CD4  B6 male  39,  >190 (x 4)sll 
Experiment  2 
A  Control rat  IgG  B6 female  16,  22,  26,  26,  26 
B  Control rat IgG  B6 male  26,  33,  37,  42,  635 
C  Anti-CD4  B6 female  19, 22,  26,  26,  28 
D  Anti-CD4  B6 male  42,  >151  (x 4)Sll 
* 5  x  107 spleen cells intraperitoneally. 
* B6 male skin grafts  applied 63 d after cells were  injected.  Five female hosts per treatment group. 
S Significantly ~  <.01) prolonged survival compared with group A. 
II Significantly (p <.05) prolonged survival compared with group B. 
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priming (Fig.  1 b) or skin graft survival (Table 2), whereas 
mice in the other treatment groups were not tolerant. Thus, 
tolerance can be achieved by transient depletion of either the 
potential helper (CD4 +) or effector (CD8 +) population. 
Persistence of Male Cells in Lymphodepleted Females,  We 
wished to determine directly whether persisting male cells 
could be found in females that had been depleted of CD4 + 
or CD8 + cells at  the time of injection of the male cells. 
Q 
Using essentially the same protocol as described earlier for  g 
tolerance induction, equivalent depleting injections of anti-  ~ 
CD4 or anti-CD8 mAbs, or control rat IgG, were given to 
B6-Thy-l.1 females which then received 5  x  107 B6 male  z  ~ 
(Thy-l.2) T  cell-enriched spleen and lymph node cells. 
Host females were killed 1, 5,  and 9 wk later,  and their 
spleen and lymph node cells analyzed separately for persis-  ~. 
tent Thy-l.2 + male cells by FACS  |  At  1 wk,  Thy-l.2 + 
cells were easily detectable in mice in all three antibody treat- 
ment groups (data not shown). At the 5- and 9-wk points,  "  ~ 
Thy-l.2 + cells were found in spleen and lymph node prepa- 
rations from females depleted initially of either CD4 + or 
CD8 + cells, but not in females given control IgG. Percen- 
tages of Thy-l.2 + cells in the T  cell-enriched populations 
that were analyzed at 9 wk are shown in Fig. 2. From knowl- 
edge of the numbers of cells in the spleen and lymph nodes 
of the mice, and the extent of T  cell enrichment by anti-Ia 
treatment, we calculate that in CD4-depleted mice, 0.28% 
of the lymph node cells, and 0.99% of the spleen cells were 
Thy-l.2 + male cells  at 9  wk (Fig.  2,  a  and d).  In CDS- 
depleted mice, 0.1% of the lymph node cells and 0.06% of 
the spleen cells were male cells (Fig. 2, b and e). Fewer than 
1 in 104 of the T cell-enriched spleen and lymph node popu- 
lations from control IgG-treated mice were Thy-l.2 + (Fig. 
2,  c and J). 
The key finding is that male cells were detectable, albeit 
in small numbers, only in females given treatments that suc- 
cessfully induced tolerance, and were apparently eradicated 
in females shown to be nonintolerant. 
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Figure  2.  Thy-l.2 + B6 male lymphocytes remaining in lymph nodes 
(a-c) or spleen (d-~) of B6-Thy-l.1 females that were treated 9 wk earlier 
with anti-CD4 (a and d), anti-CD8 (b and e), or control rat IgG (c and 
]) and given an injection of T cell-enriched male cells spleen and lymph 
node cells. Numbers indicate percentage of Thy-l.2 § cells detected by 
FACS  |  analysis in Ia + cell-depleted spleen and lymph node populations. 
See text for percentages  of male cells per organ. 
Table  2.  Survival of Male Skin  Grafts on Females Temporarily Depleted of CD4 + T  Cells 
Group  mAb treatment  Injected cells  Skin graft survival 
d 
A  Control  rat  IgG  B6  female*  16,  22,  26,  26,  26* 
B  Control rat IgG  B6 male  26, 33,  37, 42, 63s 
C  anti-CD8  B6 female  26, 26,  26, 26,  26 
D  anti-CD8  B6 male  >190 ( x 5)Sll 
" 5  x  10  ? spleen cells intraperitoneally. 
* B6 male skin grafts applied 63 d after cells were injected. Five female hosts per treatment group. 
S Significantly  (p <.01) prolonged survival compared with group A. 
N  Significantly  (p <.01) prolonged survival  compared with group B. 
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Our  results  show that  injection of male lymphoid cells 
into female mice concurrently depleted of CD4 + or CD8 + 
T  cells makes the mice tolerant of H-Y antigen later on, as 
evidenced by an inability to generate H-Y-specific CTL or 
to reject male skin grafts.  Assessment of tolerance by skin 
grafting is pertinent because in some cases, female mice may 
be unable to generate H-Y-specific CTL, yet still able to re- 
ject male tissue grafts  (7-9). 
It was also found that females that became tolerant in these 
experiments harbored male cells in their spleens and lymph 
nodes, whereas females that were not tolerant, because they 
had not been temporarily depleted of CD4 + or CD8 + cells, 
did not possess male cells. In other words, tolerance was cor- 
related with persistence of injected male cells in the females' 
lymphoid organs. A number of studies have suggested that 
a persistent source of antigen or cdlular chimerism is needed 
to sustain tolerance (14-18). Our observations provide direct 
evidence of such a source. 
Our results also show that it is not obligatory to deplete 
helper ceils in order to achieve tolerance experimentally. Most 
other models of tolerance induction-including neonatal toler- 
ance,  or tolerance induced in adults that  have been irradi- 
ated, given pharmacological agents, or treated with depleting 
antibodies-involve introduction of antigen into hosts that 
are physically or functionally depleted of potentially antigen- 
reactive ceils.  In almost aU cases, this physical or functional 
depletion has not been specifically directed at helper ceils versus 
other types of cells. Thus, it would not be apparent that deple- 
tion of hdper ceils may not be obligatory to achieve tolerance. 
At an elementary level,  the tolerance observed in our ex- 
periments can be explained on the basis of our interference, 
using depleting antibodies, with the ability of female mice 
to reject male lymphoid cells that we injected. This appar- 
ently allowed the injected cells to establish themselves in the 
females,  and this somehow sufficed to create and maintain 
a state of tolerance.  This explanation,  consistent with pub- 
lished findings (19-21), implies that tolerance can be induced 
by any procedure that blocks rejection of introduced ceils and 
allows the establishment  of a state of persistent lymphoid 
chimerism  in  the host. 
At a deeper level, however, our results do not answer the 
question of whether extrathymic tolerance occurs as a result 
of an encounter between antigen and a potentially respon- 
sive cell in the absence of a costimulus. It might seem that 
the  tolerance  induced  in  females  depleted  of CD8 +  cells 
could  not  have  occurred  in  this  way.  Potentially  reactive 
CD8 + cells in these females could never have encountered 
H-Y antigen at a time when the hosts did not also have a 
full  complement  of  CD4 +  cells.  However,  speculative 
scenarios  can  be  constructed  for  our  findings  in  CD8 +- 
depleted mice that  accommodate  the Bretscher  and Cohn 
model (1). For example, the injected male cells may be im- 
munogenic for only a brief period of time either because APCs 
deliver costimulatory signals for only a limited time after ac- 
quiring  exogenous  H-Y  antigen,  or  because  responding 
CD4 + cells provide help to CD8 + cells  for only a limited 
time. In either case, costimulation or help would have waned 
long before there was repopulation of CD8 + ceils,  and de- 
spite the host possessing both antigen and CD4 + cells, the 
CD8 +  calls  would  not  receive costimulatory  signals'  and 
thus would be anergized. Alternatively, unrejected male ceils 
in lymphodepleted female hosts would eventually become sys- 
temically dispersed (22), unlike freshly injected cells concen- 
trated at an injection site or in draining lymph nodes. Thus, 
at times long after injection, the probability would be very 
low that  a potentially responsive CD8 + cell encountering 
a male call would simultaneously be near  a source of help 
from  a  CD4 +  cell  encountering  male  antigen  associated 
with MHC class II antigen on an APC. Incidentally,  such 
a scenario could explain why intravenously injected male ceUs, 
which disperse rapidly,  induce hyporesponsiveness to male 
skin  grafts,  even in  female mice  that  are not  temporarily 
depleted of CD4 + or CD8 + ceils  (13,  23). 
Because of the innate attractiveness of the Bretscher and 
Cohn model in explaining tolerance (1), and its compatibility 
with a large body of experimental evidence, it is possible that 
further study will reveal that one or another of the scenarios 
just outlined is indeed correct. 
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